Floatz logo

11 assets in Secondary Malignant Neoplasm

Therapeutic assets addressing Secondary Malignant Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Capecitabine
Secondary Malignant Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen UniversityP3BB (66)
Oxaliplatin
Secondary Malignant Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen UniversityP3BB (65)
Sacubitril Valsartan
Secondary Malignant Neoplasm
Silesian Centre for Heart DiseasesP4BB (65)
Irinotecan
Secondary Malignant Neoplasm
Ludwig-Maximilians - University of MunichP2BB (64)
Bicalutamide
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum ZuidP2/3B (57)
Everolimus
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum ZuidP2/3B (57)
Fluorouracilum
Secondary Malignant Neoplasm
Ludwig-Maximilians - University of MunichP2B (57)
Itraconazole
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum ZuidP2/3B (57)
Letrozole
Secondary Malignant Neoplasm
Gynaecologisch Oncologisch Centrum ZuidP2/3B (57)
Panitumumab
Secondary Malignant Neoplasm
Ludwig-Maximilians - University of MunichP2CCC (53)
sy001
Secondary Malignant Neoplasm
Cell Origin Biotech (Hangzhou) Co., Ltd.N/AD (30)